Aquestive Therapeutics, Inc.AQ.STNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+29.3%
5Y CAGR+16.6%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+29.3%/yr
vs +3.9%/yr prior
5Y CAGR
+16.6%/yr
Recent acceleration
Acceleration
+25.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.87 | +32.7% |
| 2024 | 2.92 | +20.8% |
| 2023 | 2.42 | +35.0% |
| 2022 | 1.79 | -29.3% |
| 2021 | 2.53 | +41.0% |
| 2020 | 1.79 | -14.0% |
| 2019 | 2.09 | +35.7% |
| 2018 | 1.54 | -37.4% |
| 2017 | 2.45 | +3.2% |
| 2016 | 2.38 | - |